Journal of Pediatrics, The, ISSN 0022-3476, 2009, Volume 155, Issue 6, pp. 829 - 833
Objective To assess the feasibility of T-cell receptor excision circles (TRECs) quantification for neonatal mass screening of severe combined immunodeficiency...
Pediatrics | PEDIATRICS | Predictive Value of Tests | Severe Combined Immunodeficiency - diagnosis | Humans | Middle Aged | Child, Preschool | Infant | Male | Neonatal Screening - methods | DNA Repair - genetics | Reverse Transcriptase Polymerase Chain Reaction | Feasibility Studies | Young Adult | Severe Combined Immunodeficiency - genetics | Adolescent | Severe Combined Immunodeficiency - blood | Ribonuclease P - blood | Adult | Female | Receptors, Antigen, T-Cell - genetics | Child | Infant, Newborn | Infants (Newborn) | Allergy | Medical colleges | Severe combined immunodeficiency | Immunodeficiency | Transplantation | T cells | Medical screening | Allergic reaction | Hematopoietic stem cells | Polymerase chain reaction | Bone marrow | Cytogenetics | Children | Health aspects | Medical informatics
Pediatrics | PEDIATRICS | Predictive Value of Tests | Severe Combined Immunodeficiency - diagnosis | Humans | Middle Aged | Child, Preschool | Infant | Male | Neonatal Screening - methods | DNA Repair - genetics | Reverse Transcriptase Polymerase Chain Reaction | Feasibility Studies | Young Adult | Severe Combined Immunodeficiency - genetics | Adolescent | Severe Combined Immunodeficiency - blood | Ribonuclease P - blood | Adult | Female | Receptors, Antigen, T-Cell - genetics | Child | Infant, Newborn | Infants (Newborn) | Allergy | Medical colleges | Severe combined immunodeficiency | Immunodeficiency | Transplantation | T cells | Medical screening | Allergic reaction | Hematopoietic stem cells | Polymerase chain reaction | Bone marrow | Cytogenetics | Children | Health aspects | Medical informatics
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 11, pp. 2603 - 2608
Summary Ossifying fibromyxoid tumor is a rare soft tissue tumor of borderline malignancy and uncertain differentiation. Recently, a novel fusion gene,...
Pathology | EP400 | Ossifying fibromyxoid tumor | PHF1 | RT-PCR | Fusion gene | REARRANGEMENT | SOFT PARTS | SARCOMA | CYTOGENETIC FINDINGS | PATHOLOGY | CHROMOSOMAL-ABERRATIONS | FEATURES | Fibroma, Ossifying - genetics | Immunohistochemistry | Translocation, Genetic | Humans | Molecular Sequence Data | DNA-Binding Proteins - metabolism | Base Sequence | Female | Cytogenetic Analysis | Chromosomes, Human, Pair 12 - genetics | DNA Helicases - genetics | Soft Tissue Neoplasms - genetics | Gene Fusion | Fibroma, Ossifying - pathology | Hand - diagnostic imaging | Polycomb-Group Proteins | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | Sequence Analysis, DNA | Chromosomes, Human, Pair 6 - genetics | Radiography | Transcription Factors - metabolism | DNA Helicases - metabolism | Disease-Free Survival | Soft Tissue Neoplasms - pathology | Aged | Karyotype | Genetic research | DNA polymerases | Genes | Tumors | Proteins | Medical research | Surgery
Pathology | EP400 | Ossifying fibromyxoid tumor | PHF1 | RT-PCR | Fusion gene | REARRANGEMENT | SOFT PARTS | SARCOMA | CYTOGENETIC FINDINGS | PATHOLOGY | CHROMOSOMAL-ABERRATIONS | FEATURES | Fibroma, Ossifying - genetics | Immunohistochemistry | Translocation, Genetic | Humans | Molecular Sequence Data | DNA-Binding Proteins - metabolism | Base Sequence | Female | Cytogenetic Analysis | Chromosomes, Human, Pair 12 - genetics | DNA Helicases - genetics | Soft Tissue Neoplasms - genetics | Gene Fusion | Fibroma, Ossifying - pathology | Hand - diagnostic imaging | Polycomb-Group Proteins | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Reverse Transcriptase Polymerase Chain Reaction | Sequence Analysis, DNA | Chromosomes, Human, Pair 6 - genetics | Radiography | Transcription Factors - metabolism | DNA Helicases - metabolism | Disease-Free Survival | Soft Tissue Neoplasms - pathology | Aged | Karyotype | Genetic research | DNA polymerases | Genes | Tumors | Proteins | Medical research | Surgery
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 4, pp. 793 - 801
Summary We previously reported a case of immunoglobulin (Ig)G4-related immune inflammation in Warthin tumor. Increased serum IgG4 levels and tissue...
Pathology | Warthin tumor | Class-switch recombination | IgG4-related disease | ACTIVATION | INDUCED CYTIDINE DEAMINASE | IGE | ADENOLYMPHOMA | PATHOLOGY | MIKULICZS-DISEASE | B-CELLS | SCLEROSING PANCREATITIS | DIFFERENTIATION | TH2 | Adenolymphoma - blood | Immunoglobulin G - blood | Adenolymphoma - immunology | Humans | Middle Aged | Immunoglobulin Class Switching - immunology | Male | Reverse Transcriptase Polymerase Chain Reaction | Plasma Cells - pathology | Immunoglobulin G - immunology | Adenolymphoma - pathology | Adult | Aged | Plasma Cells - immunology | Adenolymphoma | RNA | Immunoglobulin G | Analysis | Polymerase chain reaction | Plasma | Immunoglobulins | Cytokines | Genes | Hypothyroidism | Age | Tumors
Pathology | Warthin tumor | Class-switch recombination | IgG4-related disease | ACTIVATION | INDUCED CYTIDINE DEAMINASE | IGE | ADENOLYMPHOMA | PATHOLOGY | MIKULICZS-DISEASE | B-CELLS | SCLEROSING PANCREATITIS | DIFFERENTIATION | TH2 | Adenolymphoma - blood | Immunoglobulin G - blood | Adenolymphoma - immunology | Humans | Middle Aged | Immunoglobulin Class Switching - immunology | Male | Reverse Transcriptase Polymerase Chain Reaction | Plasma Cells - pathology | Immunoglobulin G - immunology | Adenolymphoma - pathology | Adult | Aged | Plasma Cells - immunology | Adenolymphoma | RNA | Immunoglobulin G | Analysis | Polymerase chain reaction | Plasma | Immunoglobulins | Cytokines | Genes | Hypothyroidism | Age | Tumors
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 12, pp. 2845 - 2848
Summary Malignant peripheral nerve sheath tumor is a malignant tumor showing nerve sheath differentiation. Approximately one-half of malignant peripheral nerve...
Pathology | SMARCB1 | Malignant transformation | Malignant peripheral nerve sheath tumor | Schwannoma | TRANSFORMATION | PATHOLOGY | Neurilemmoma - surgery | Humans | Middle Aged | Treatment Outcome | Back - pathology | Back - surgery | Neurilemmoma - pathology | Soft Tissue Neoplasms - surgery | Nerve Sheath Neoplasms - surgery | Nerve Sheath Neoplasms - pathology | Soft Tissue Neoplasms - pathology | Female | Cell Transformation, Neoplastic - pathology | Nerve proteins | Tumors | Proteins | Smooth muscle | Ostomy | Muscular system | Pathogenesis
Pathology | SMARCB1 | Malignant transformation | Malignant peripheral nerve sheath tumor | Schwannoma | TRANSFORMATION | PATHOLOGY | Neurilemmoma - surgery | Humans | Middle Aged | Treatment Outcome | Back - pathology | Back - surgery | Neurilemmoma - pathology | Soft Tissue Neoplasms - surgery | Nerve Sheath Neoplasms - surgery | Nerve Sheath Neoplasms - pathology | Soft Tissue Neoplasms - pathology | Female | Cell Transformation, Neoplastic - pathology | Nerve proteins | Tumors | Proteins | Smooth muscle | Ostomy | Muscular system | Pathogenesis
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 5, pp. 984 - 993
Summary The Akt/mammalian target of rapamycin (mTOR) pathway plays important roles in modulating cellular function in response to extracellular signals such as...
Pathology | mTOR | Myxofibrosarcoma | Akt | MAPK | PATHOLOGY | SOFT-TISSUE TUMORS | GROWTH-FACTOR RECEPTOR | INHIBITION | SARCOMA | CARCINOMAS | PROGNOSTIC-SIGNIFICANCE | BONE | HUMAN CANCER | Histiocytoma, Malignant Fibrous - pathology | Fibrosarcoma - physiopathology | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Histiocytoma, Malignant Fibrous - physiopathology | Male | Dermatofibrosarcoma - physiopathology | Disease Progression | Proto-Oncogene Proteins c-akt - genetics | Dermatofibrosarcoma - pathology | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Fibrosarcoma - pathology | Aged, 80 and over | Adult | Female | Signal Transduction - physiology | Aged | Proto-Oncogene Proteins c-akt - metabolism | Mitogen-Activated Protein Kinases - metabolism | Immunohistochemistry | Sarcoma | Analysis | Development and progression | Genetic translation | Mitogens | Formaldehyde | Protein binding | Gene mutations | College graduates | Protein kinases | Proteins | Survival analysis | Kinases | Tumors
Pathology | mTOR | Myxofibrosarcoma | Akt | MAPK | PATHOLOGY | SOFT-TISSUE TUMORS | GROWTH-FACTOR RECEPTOR | INHIBITION | SARCOMA | CARCINOMAS | PROGNOSTIC-SIGNIFICANCE | BONE | HUMAN CANCER | Histiocytoma, Malignant Fibrous - pathology | Fibrosarcoma - physiopathology | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Histiocytoma, Malignant Fibrous - physiopathology | Male | Dermatofibrosarcoma - physiopathology | Disease Progression | Proto-Oncogene Proteins c-akt - genetics | Dermatofibrosarcoma - pathology | Phosphatidylinositol 3-Kinases - genetics | Class I Phosphatidylinositol 3-Kinases | Fibrosarcoma - pathology | Aged, 80 and over | Adult | Female | Signal Transduction - physiology | Aged | Proto-Oncogene Proteins c-akt - metabolism | Mitogen-Activated Protein Kinases - metabolism | Immunohistochemistry | Sarcoma | Analysis | Development and progression | Genetic translation | Mitogens | Formaldehyde | Protein binding | Gene mutations | College graduates | Protein kinases | Proteins | Survival analysis | Kinases | Tumors
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 2, pp. 276 - 284
Summary Activating transcription factor 2 (ATF2) is a member of activator protein 1 superfamily, which can heterodimerize with other transcription factors...
Pathology | Immunohistochemistry | Mesenchymal tumor | Activating transcription factor 2 | Translocation-associated sarcoma | Transcription factor | SYNOVIAL SARCOMA | ATF2 | TLE1 | NUCLEAR | PATHOLOGY | RADIATION | CANCER | HUMAN-MELANOMA CELLS | RESISTANCE | DIAGNOSTIC IMMUNOHISTOCHEMICAL MARKER | EXPRESSION | Cell Nucleus - metabolism | Neoplasms, Connective and Soft Tissue - genetics | Sarcoma, Synovial - genetics | Activating Transcription Factor 2 - biosynthesis | Tissue Array Analysis | Activating Transcription Factor 2 - immunology | Humans | Sarcoma, Synovial - metabolism | Cytoplasm - metabolism | Activating Transcription Factor 2 - genetics | Neoplasms, Connective and Soft Tissue - metabolism | Endometrial cancer | Sarcoma | Analysis | Melanoma | Proteins | Bone cancer | Transcription factors | Lymphomas | Tumorigenesis | Deoxyribonucleic acid--DNA | Tumors
Pathology | Immunohistochemistry | Mesenchymal tumor | Activating transcription factor 2 | Translocation-associated sarcoma | Transcription factor | SYNOVIAL SARCOMA | ATF2 | TLE1 | NUCLEAR | PATHOLOGY | RADIATION | CANCER | HUMAN-MELANOMA CELLS | RESISTANCE | DIAGNOSTIC IMMUNOHISTOCHEMICAL MARKER | EXPRESSION | Cell Nucleus - metabolism | Neoplasms, Connective and Soft Tissue - genetics | Sarcoma, Synovial - genetics | Activating Transcription Factor 2 - biosynthesis | Tissue Array Analysis | Activating Transcription Factor 2 - immunology | Humans | Sarcoma, Synovial - metabolism | Cytoplasm - metabolism | Activating Transcription Factor 2 - genetics | Neoplasms, Connective and Soft Tissue - metabolism | Endometrial cancer | Sarcoma | Analysis | Melanoma | Proteins | Bone cancer | Transcription factors | Lymphomas | Tumorigenesis | Deoxyribonucleic acid--DNA | Tumors
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 6, pp. 1184 - 1189
Summary Bone infarct-associated sarcoma is a rare sarcoma, accounting for less than 1% of all bone sarcomas. Its histology usually reflects a high-grade...
Pathology | Infarct associated sarcoma | Osteosarcoma | Secondary osteosarcoma | Low-grade central osteosarcoma | Bone infarct | Keywords | SARCOMA | MALIGNANT FIBROUS HISTIOCYTOMA | MDM2 | PATHOLOGY | Low-grade central osteosarcorna | ASSOCIATION | FEATURES | Immunohistochemistry | Young Adult | Infarction - complications | Humans | Osteosarcoma - etiology | Bone and Bones - blood supply | Adult | Female | Bone Neoplasms - pathology | Bone Neoplasms - etiology | Osteosarcoma - pathology | Histology | Sickle cell anemia | Mutation | Radiation therapy
Pathology | Infarct associated sarcoma | Osteosarcoma | Secondary osteosarcoma | Low-grade central osteosarcoma | Bone infarct | Keywords | SARCOMA | MALIGNANT FIBROUS HISTIOCYTOMA | MDM2 | PATHOLOGY | Low-grade central osteosarcorna | ASSOCIATION | FEATURES | Immunohistochemistry | Young Adult | Infarction - complications | Humans | Osteosarcoma - etiology | Bone and Bones - blood supply | Adult | Female | Bone Neoplasms - pathology | Bone Neoplasms - etiology | Osteosarcoma - pathology | Histology | Sickle cell anemia | Mutation | Radiation therapy
Journal Article
SAGE Open Nursing, ISSN 2377-9608, 2/2018, Volume 4, p. 237796081875679
Abstract Background Although a majority of nurses understand that delirium is a major issue in perioperative care, professional barriers to routine monitoring...
Delirium
Delirium
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 2, pp. 237 - 243
Summary Clear cell chondrosarcoma is a rare cartilaginous bone tumor, and little is known about its pathology. We investigated the immunohistochemical...
Pathology | Clear cell chondrosarcoma | Cytokeratin | Sox9 | Chondroblastoma | Runx2 | TISSUE | CYTOKERATIN EXPRESSION | PATHOLOGY | OSTEOCALCIN | GENE | EMPHASIS | OSTEOSARCOMA | BONE | OSTEONECTIN | Immunohistochemistry | SOX9 Transcription Factor - metabolism | Mucin-1 - metabolism | Humans | Middle Aged | Male | Bone Neoplasms - pathology | Core Binding Factor Alpha 1 Subunit - metabolism | Bone Neoplasms - metabolism | Young Adult | Keratins - metabolism | Chondrosarcoma - metabolism | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Chondroblastoma - metabolism | Chondrosarcoma - pathology | Adult | Female | Aged | Cell Differentiation | Child | Chondroblastoma - pathology | Antigens | Keratin | Analysis | Collagen | Proteins | Chemotherapy | Mutation | Tumors
Pathology | Clear cell chondrosarcoma | Cytokeratin | Sox9 | Chondroblastoma | Runx2 | TISSUE | CYTOKERATIN EXPRESSION | PATHOLOGY | OSTEOCALCIN | GENE | EMPHASIS | OSTEOSARCOMA | BONE | OSTEONECTIN | Immunohistochemistry | SOX9 Transcription Factor - metabolism | Mucin-1 - metabolism | Humans | Middle Aged | Male | Bone Neoplasms - pathology | Core Binding Factor Alpha 1 Subunit - metabolism | Bone Neoplasms - metabolism | Young Adult | Keratins - metabolism | Chondrosarcoma - metabolism | Adolescent | Aged, 80 and over | Biomarkers, Tumor - metabolism | Chondroblastoma - metabolism | Chondrosarcoma - pathology | Adult | Female | Aged | Cell Differentiation | Child | Chondroblastoma - pathology | Antigens | Keratin | Analysis | Collagen | Proteins | Chemotherapy | Mutation | Tumors
Journal Article
Journal of Cardiology, ISSN 0914-5087, 2011, Volume 57, Issue 1, pp. 44 - 52
Summary Background and purpose The long-term safety and efficacy of primary stenting using drug-eluting stents (DES) in patients with ST-segment elevation...
Cardiovascular | Myocardial infarction | Stent thrombosis | Angioplasty | Drug-eluting stent | REVASCULARIZATION | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RANDOMIZED-TRIAL | ANTIPLATELET THERAPY | PERCUTANEOUS CORONARY INTERVENTION | UNDEREXPANSION | IMPLANTATION | ARTERY | REGISTRY | Drug-Eluting Stents | Follow-Up Studies | Humans | Coronary Restenosis | Male | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Coronary Angiography | Myocardial Infarction - therapy | Sirolimus - administration & dosage | Female | Myocardial Infarction - physiopathology | Aged | Coronary Thrombosis - etiology | Retrospective Studies | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects
Cardiovascular | Myocardial infarction | Stent thrombosis | Angioplasty | Drug-eluting stent | REVASCULARIZATION | MULTICENTER | CARDIAC & CARDIOVASCULAR SYSTEMS | THROMBOSIS | RANDOMIZED-TRIAL | ANTIPLATELET THERAPY | PERCUTANEOUS CORONARY INTERVENTION | UNDEREXPANSION | IMPLANTATION | ARTERY | REGISTRY | Drug-Eluting Stents | Follow-Up Studies | Humans | Coronary Restenosis | Male | Treatment Outcome | Myocardial Infarction - diagnostic imaging | Coronary Angiography | Myocardial Infarction - therapy | Sirolimus - administration & dosage | Female | Myocardial Infarction - physiopathology | Aged | Coronary Thrombosis - etiology | Retrospective Studies | Platelet Aggregation Inhibitors - therapeutic use | Stents - adverse effects
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 1, pp. 93 - 101
Purpose Investigation of the treatment potential of carbon-ion radiation therapy in pelvic recurrence of rectal cancer. Methods and Materials A phase 1/2 dose...
Radiology | Hematology, Oncology and Palliative Medicine | DOSE-ESCALATION | UTERINE CERVIX | HEAD | HEPATOCELLULAR-CARCINOMA | RADICAL SURGERY | ONCOLOGY | RESECTION | PROSTATE-CANCER | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TOTAL MESORECTAL EXCISION | NECK-CANCER | Japan - epidemiology | Neoplasm Recurrence, Local - radiotherapy | Prevalence | Humans | Middle Aged | Risk Factors | Pelvic Neoplasms - mortality | Male | Survival Rate | Treatment Outcome | Heavy Ion Radiotherapy - mortality | Neoplasm Recurrence, Local - mortality | Carbon | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Heavy Ion Radiotherapy - statistics & numerical data | Disease-Free Survival | Pelvic Neoplasms - prevention & control | Dose Hypofractionation | Adult | Female | Aged | Dose-Response Relationship, Radiation | Medical colleges | Care and treatment | Relapse | Colorectal cancer | College graduates | Radiation | Radiotherapy | Diseases | PATIENTS | NEOPLASMS | RBE | RECTUM | GY RANGE 01-10 | RADIOLOGY AND NUCLEAR MEDICINE | CARBON IONS | GY RANGE 10-100 | ABSORBED RADIATION DOSES
Radiology | Hematology, Oncology and Palliative Medicine | DOSE-ESCALATION | UTERINE CERVIX | HEAD | HEPATOCELLULAR-CARCINOMA | RADICAL SURGERY | ONCOLOGY | RESECTION | PROSTATE-CANCER | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | TOTAL MESORECTAL EXCISION | NECK-CANCER | Japan - epidemiology | Neoplasm Recurrence, Local - radiotherapy | Prevalence | Humans | Middle Aged | Risk Factors | Pelvic Neoplasms - mortality | Male | Survival Rate | Treatment Outcome | Heavy Ion Radiotherapy - mortality | Neoplasm Recurrence, Local - mortality | Carbon | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Heavy Ion Radiotherapy - statistics & numerical data | Disease-Free Survival | Pelvic Neoplasms - prevention & control | Dose Hypofractionation | Adult | Female | Aged | Dose-Response Relationship, Radiation | Medical colleges | Care and treatment | Relapse | Colorectal cancer | College graduates | Radiation | Radiotherapy | Diseases | PATIENTS | NEOPLASMS | RBE | RECTUM | GY RANGE 01-10 | RADIOLOGY AND NUCLEAR MEDICINE | CARBON IONS | GY RANGE 10-100 | ABSORBED RADIATION DOSES
Journal Article
Journal of Cardiology, ISSN 0914-5087, 2015, Volume 67, Issue 1, pp. 22 - 27
Abstract Omega-3 polyunsaturated fatty acids (PUFAs), such as eicosapentaenoic acid and docosahexaenoic acid, are widely regarded as cardioprotective. Several...
Cardiovascular | 18-Hydroxyeicosapentaenoic acid | Cardiovascular disease | Omega-3 polyunsaturated fatty acids | Anti-inflammation | Specialized proresolving mediators | CARDIAC & CARDIOVASCULAR SYSTEMS | OMEGA-3-FATTY-ACIDS | RESOLUTION | PREVENTION | DOCOSAHEXAENOIC ACID | INSULIN-RESISTANCE | INFLAMMATION | FISH-OIL | CHANNELS | EICOSAPENTAENOIC ACID | AGONIST | Cardiotonic Agents - pharmacology | Vascular Remodeling - drug effects | Anti-Inflammatory Agents - pharmacology | Fatty Acids, Omega-3 - pharmacology | Anti-Arrhythmia Agents - pharmacology | Humans
Cardiovascular | 18-Hydroxyeicosapentaenoic acid | Cardiovascular disease | Omega-3 polyunsaturated fatty acids | Anti-inflammation | Specialized proresolving mediators | CARDIAC & CARDIOVASCULAR SYSTEMS | OMEGA-3-FATTY-ACIDS | RESOLUTION | PREVENTION | DOCOSAHEXAENOIC ACID | INSULIN-RESISTANCE | INFLAMMATION | FISH-OIL | CHANNELS | EICOSAPENTAENOIC ACID | AGONIST | Cardiotonic Agents - pharmacology | Vascular Remodeling - drug effects | Anti-Inflammatory Agents - pharmacology | Fatty Acids, Omega-3 - pharmacology | Anti-Arrhythmia Agents - pharmacology | Humans
Journal Article
Human Pathology, ISSN 0046-8177, 2012, Volume 43, Issue 6, pp. 850 - 857
Summary We recognized immunoreactivity for the α subset of inhibin and synaptophysin in synovial sarcomas with granular cell features. Histologic findings of...
Pathology | Synaptophysin | Granular cell features | Synovial sarcoma | Unusual histology | Inhibin | DIAGNOSIS | FUSION | NERVE SHEATH TUMOR | MARKERS | PATHOLOGY | CALRETININ | CORD-STROMAL TUMORS | SYT | KIDNEY | MALIGNANT MESOTHELIOMA | CARCINOMA | Immunohistochemistry | Microscopy, Electron, Transmission | Humans | Soft Tissue Neoplasms - metabolism | Sarcoma, Synovial - metabolism | Reverse Transcriptase Polymerase Chain Reaction | In Situ Hybridization | Sarcoma, Synovial - genetics | Soft Tissue Neoplasms - ultrastructure | Inhibins - biosynthesis | Synaptophysin - biosynthesis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Female | Aged | Retrospective Studies | Soft Tissue Neoplasms - genetics | Sarcoma, Synovial - ultrastructure
Pathology | Synaptophysin | Granular cell features | Synovial sarcoma | Unusual histology | Inhibin | DIAGNOSIS | FUSION | NERVE SHEATH TUMOR | MARKERS | PATHOLOGY | CALRETININ | CORD-STROMAL TUMORS | SYT | KIDNEY | MALIGNANT MESOTHELIOMA | CARCINOMA | Immunohistochemistry | Microscopy, Electron, Transmission | Humans | Soft Tissue Neoplasms - metabolism | Sarcoma, Synovial - metabolism | Reverse Transcriptase Polymerase Chain Reaction | In Situ Hybridization | Sarcoma, Synovial - genetics | Soft Tissue Neoplasms - ultrastructure | Inhibins - biosynthesis | Synaptophysin - biosynthesis | Aged, 80 and over | Biomarkers, Tumor - metabolism | Female | Aged | Retrospective Studies | Soft Tissue Neoplasms - genetics | Sarcoma, Synovial - ultrastructure
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9898, pp. 1105 - 1112
Summary Background Staples have been widely used for skin closure after open gastrointestinal surgery. The potential advantages of subcuticular sutures...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | LAPAROTOMY | SURGICAL SITE INFECTION | ANTIMICROBIAL PROPHYLAXIS | PREVENTION | WOUND-INFECTION | Length of Stay | Cicatrix, Hypertrophic - etiology | Humans | Middle Aged | Sutures - adverse effects | Male | Treatment Outcome | Digestive System Surgical Procedures - adverse effects | Surgical Wound Infection - etiology | Surgical Stapling - adverse effects | Gastrointestinal Diseases - surgery | Female | Aged | Wound Healing - physiology | Suturing | Usage | Comparative analysis | Staplers (Surgery) | Health care | Disease prevention | Wound healing | Hospitals | Gastrointestinal surgery | Patient satisfaction | Cancer
Internal Medicine | MEDICINE, GENERAL & INTERNAL | IMPACT | LAPAROTOMY | SURGICAL SITE INFECTION | ANTIMICROBIAL PROPHYLAXIS | PREVENTION | WOUND-INFECTION | Length of Stay | Cicatrix, Hypertrophic - etiology | Humans | Middle Aged | Sutures - adverse effects | Male | Treatment Outcome | Digestive System Surgical Procedures - adverse effects | Surgical Wound Infection - etiology | Surgical Stapling - adverse effects | Gastrointestinal Diseases - surgery | Female | Aged | Wound Healing - physiology | Suturing | Usage | Comparative analysis | Staplers (Surgery) | Health care | Disease prevention | Wound healing | Hospitals | Gastrointestinal surgery | Patient satisfaction | Cancer
Journal Article
Clinical Orthopaedics and Related Research, ISSN 0009-921X, 12/2013, Volume 471, Issue 12, pp. 4082 - 4086
The local and systemic effects of wear debris and corrosion products remain a concern in arthroplasty and reaction to corrosion or wear products from modular...
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | ARTHROPLASTY | CORROSION | PSEUDOTUMOR | PREVALENCE | RELEASE | ORTHOPEDICS | TAPER | Reoperation | Hemiarthroplasty - adverse effects | Prosthesis Failure | Hip Joint - surgery | Humans | Range of Motion, Articular | Hip Prosthesis - adverse effects | Male | Aged | Arthroplasty, Replacement, Hip - adverse effects | Case Report
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | ARTHROPLASTY | CORROSION | PSEUDOTUMOR | PREVALENCE | RELEASE | ORTHOPEDICS | TAPER | Reoperation | Hemiarthroplasty - adverse effects | Prosthesis Failure | Hip Joint - surgery | Humans | Range of Motion, Articular | Hip Prosthesis - adverse effects | Male | Aged | Arthroplasty, Replacement, Hip - adverse effects | Case Report
Journal Article